HK이노엔(195940) IR & PR 공식채널
Open in Telegram
1 625
Subscribers
No data24 hours
-37 days
-730 days
Data loading in progress...
Similar Channels
No data
Any problems? Please refresh the page or contact our support manager.
Tags Cloud
No data
Any problems? Please refresh the page or contact our support manager.
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
September '26
September '26
+2
in 0 channels
August '26
+8
in 0 channels
Get PRO
July '26
+11
in 1 channels
Get PRO
June '26
+44
in 6 channels
Get PRO
May '26
+11
in 1 channels
Get PRO
April '26
+12
in 0 channels
Get PRO
March '26
+3
in 0 channels
Get PRO
February '26
+18
in 3 channels
Get PRO
January '26
+57
in 16 channels
Get PRO
December '25
+29
in 7 channels
Get PRO
November '25
+24
in 0 channels
Get PRO
October '25
+46
in 10 channels
Get PRO
September '25
+56
in 11 channels
Get PRO
August '25
+72
in 4 channels
Get PRO
July '25
+20
in 2 channels
Get PRO
June '25
+85
in 16 channels
Get PRO
May '25
+36
in 2 channels
Get PRO
April '25
+145
in 23 channels
Get PRO
March '25
+25
in 4 channels
Get PRO
February '25
+18
in 0 channels
Get PRO
January '25
+36
in 3 channels
Get PRO
December '24
+32
in 5 channels
Get PRO
November '24
+67
in 13 channels
Get PRO
October '24
+45
in 8 channels
Get PRO
September '24
+58
in 2 channels
Get PRO
August '24
+77
in 4 channels
Get PRO
July '24
+63
in 7 channels
Get PRO
June '24
+54
in 9 channels
Get PRO
May '24
+71
in 5 channels
Get PRO
April '24
+55
in 1 channels
Get PRO
March '24
+78
in 4 channels
Get PRO
February '24
+20
in 1 channels
Get PRO
January '24
+37
in 3 channels
Get PRO
December '23
+54
in 12 channels
Get PRO
November '23
+44
in 4 channels
Get PRO
October '23
+61
in 2 channels
Get PRO
September '23
+797
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 06 September | 0 | |||
| 05 September | 0 | |||
| 04 September | +1 | |||
| 03 September | 0 | |||
| 02 September | +1 | |||
| 01 September | 0 |
Channel Posts
| 2 |  No text... | 534 |
| 3 | iM증권_HK이노엔_똘똘한_한_채_같은_케이캡_20260730.pdf | 513 |
| 4 |  No text... | 479 |
| 5 | NH투자증권_HK이노엔_CAB 성과 시기_20260730.pdf | 362 |
| 6 |  No text... | 364 |
| 7 | 키움증권_HK이노엔_테고의 달인_20260730.pdf | 352 |
| 8 |  No text... | 360 |
| 9 | 금일 발간된 증권사 리포트 공유드립니다.
(Sharing reports published today) | 327 |
| 10 | +1 HK inno.N_2Q26_Earnings Release.pdf | 413 |
| 11 |  No text... | 451 |
| 12 | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260729900265 | 431 |
| 13 | 안녕하십니까 HK이노엔 IR팀입니다.
당사 소화성궤양용제 신약 케이캡이 'NSAIDs 투여와 관련된 소화성궤양 예방' 6번째 적응증을 확보하게 되어 소식을 안내 드립니다.
보도자료 링크 : https://www.inno-n.com/pr/news/view/1/1118?sch_text=
현재 케이캡의 적응증은
1. 미란성 위식도역류질환의 치료
2. 비미란성 위식도역류질환의 치료
3. 위궤양의 치료
4. 헬리코박터파일로리 제균을 위한 항생제 병용요법
5. 미란성 위식도역류질환 치료 후 유지요법
6. NSAIDs 투여와 관련된 소화성궤양 예방(금번 추가 적응증)
으로 금번 적응증 추가를 통해 광범위한 비스테로이드성 소염진통제(NSAIDs) 처방시장에서 사용량 증대가 이루어질 것으로 기대합니다.
문의사항 있으신 경우 IR팀으로 편히 연락주시기 바랍니다. 감사합니다. | 568 |
| 14 |  No text... | 587 |
| 15 | 안녕하십니까 HK이노엔 IR팀입니다. 당사 소화성궤양신약 케이캡이 국내에 이어 전세계 대형시장인 중국에서도 출시 3년만에 시장내 1위품목으로 성장하여 관련 기사자료를 공유드립니다.
https://www.medicopharma.co.kr/news/articleView.html?idxno=68833 | 592 |
| 16 | 부국증권_HK이노엔_2Q26_Preview_견조한_성장에_더해질_LO_20260713.pdf | 707 |
| 17 |  No text... | 632 |
| 18 | iM증권_HK이노엔_잠잠하게_지나가는_시기_20260713.pdf | 578 |
| 19 |  No text... | 549 |
| 20 | 다올투자증권_HK이노엔_단기_실적_노이즈_속_글로벌_모멘텀_20260713.pdf | 372 |
